NASDAQ:CBMG - Cellular Biomedicine Group, Inc.
$17.22
 $0.32
+1.89%
4:00PM EDT
2019-04-18
Cellular Biomedicine Group, Inc. (CBMG) is a biomedicine company. The Company is engaged in the development of treatments for cancerous and degenerative diseases utilizing cell-based technologies. The Company operates in Biomedicine Cell Therapy segment. The Company's technology includes platforms, such as Immune Cell therapy for treatment of broad range of cancers using Vaccine, T Cells Receptor (TCR) clonality analysis technology and T Central Memory Cell (Tcm) preparation methodologies, Chimeric Antigen Receptor T cell (CAR-T), and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases, with primary research and manufacturing facilities in China. It is focused on developing and marketing cell-based therapies based on its cellular platforms, to treat serious chronic and degenerative diseases, such as cancer, orthopedic diseases, including osteoarthritis and tissue damage, various inflammatory diseases and metabolic diseases. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CBMG     avg for
industry  
  avg for
sector  
42 stocks weight:  8. 04   199. 07   233. 87  
42 stocks rank:  3. 08 K 1. 43 K 1. 06 K
# analyst opinions:  2. 00   14. 48   14. 09  
mean recommendation:  1. 50   2. 09   2. 01  

quick ratio:  8. 58   5. 29   1. 92  
current ratio:  8. 86   5. 64   2. 40  

target price low:  26. 00   84. 50   115. 74  
target price avg:  32. 00   110. 73   137. 39  
target price high:  38. 00   136. 41   157. 80  
1-yr high:  23. 65   114. 11   138. 85  
last close:  17. 22   87. 56   116. 78  
50-day avg:  17. 84   95. 43   123. 53  
200-day avg:  18. 46   94. 13   121. 20  
1-yr low:  12. 32   72. 67   98. 41  
volume:  23. 30 K 2. 43 M 4. 85 M
50-day avg volume:  48. 73 K 2. 72 M 4. 97 M
200-day avg volume:  61. 93 K 2. 90 M 4. 58 M

1-day return:  1. 89 % -0. 40 % 0. 07 %
this week return:  0. 47 % -5. 72 % -4. 11 %
12-wk return:  0. 88 % 1. 78 % -0. 04 %
52-wk return:  -17. 90 % 10. 81 % 14. 09 %

enterprise value (EV):  257. 10 M 51. 19 B 117. 96 B
market cap:  329. 22 M 43. 00 B 104. 52 B
EBITDA:  -32. 54 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -7. 90   4. 34   13. 27  
enterprise/revenue (EV/R):  1. 15 K 68. 16   13. 68  
total revenue:  224. 40 K 10. 61 B 38. 24 B
total debt:  0. 00   12. 22 B 16. 66 B
net income (common):  -38. 95 M 2. 20 B 4. 21 B

shares outstanding:  19. 12 M 570. 91 M 1. 24 B
shares:  10. 69 M 571. 02 M 1. 23 B
shares short:  644. 51 K 9. 93 M 16. 79 M
shares short prior month:  589. 40 K 9. 96 M 16. 58 M
short ratio:  11. 52   5. 31   3. 30  
short % of float:  4. 79 % 5. 81 % 2. 61 %
total cash/share:  2. 92   11. 13   9. 30  
total cash:  52. 81 M 6. 70 B 7. 10 B
free cash flow:  -17. 48 M 3. 58 B 4. 74 B
operating cash flow:  -25. 11 M 4. 14 B 6. 32 B

book value:  4. 70   12. 76   26. 84  
price/book:  3. 66   3. 08   -1. 74  
gross profits:  88. 64 K 8. 03 B 34. 77 B
operating margins:  -16751. 75 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  39. 50 % 37. 02 % 55. 68 %

1-yr max volatility:  19. 34 % --- ---
1-yr mean volatility:  0. 01 % 0. 03 % 0. 04 %

1-yr EPS:  -2. 20   2. 39   4. 08  
forward EPS:  -2. 44   3. 97   7. 14  
P/E:  -7. 83   13. 59   22. 83  
forward P/E:  -7. 02   -20. 05   14. 49  
PE/G:  0. 13   -1. 46   1. 68  
growth:  -62. 60 % 126. 81 % 29. 29 %
earnings high:  -0. 53   1. 02   1. 63  
earnings avg:  -0. 56   0. 76   1. 51  
earnings low:  -0. 60   0. 47   1. 39  
revenue high:  50. 00 K 2. 68 B 10. 71 B
revenue avg:  50. 00 K 2. 59 B 10. 49 B
revenue low:  50. 00 K 2. 49 B 10. 25 B
return on assets:  -30. 75 % -2. 80 % 5. 29 %
return on equity:  -54. 65 % -18. 52 % 7. 38 %
revenue growth:  -62. 60 % 92. 55 % 19. 15 %
revenue/share:  0. 01   13. 27   55. 24  

beta (1yr vs S&P500):  1. 34   1. 24   0. 93  
sharpe (1yr):  0. 03   0. 29   0. 60  

held % insiders:  37. 14 % 6. 38 % 3. 38 %
held % institutions:  19. 35 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : CBMG
.     + 1.95 =          1.95 :: INITIAL WEIGHT
.  + 127.397 =       129.346 :: inverse volume-to-price addition
.    + 47.44 =       176.786 :: spline projection addition
.    x 4.014 =       709.649 :: 13 weeks' performance factor
.    x 0.892 =       633.291 :: one-year gains+dividend factor
.    x 1.432 =       906.888 :: industry recommendation factor
.     x 2.42 =      2194.453 :: symbol recommendation factor
.    x 5.007 =     10988.278 :: EV/R factor
.    x 0.997 =     10954.488 :: return on assets factor
.    x 0.995 =      10894.62 :: return on equity factor
.    x 0.994 =      10826.42 :: revenue growth factor
.     x 2.43 =     26303.233 :: current ratio factor
.    x 1.064 =     27984.325 :: quick ratio factor
.    x 1.042 =      29173.65 :: short ratio factor
.    x 2.037 =     59415.491 :: price-to-book factor
.    x 2.029 =    120553.871 :: P/E weight
.    x 1.682 =    202731.918 :: PE/G factor
.    x 1.493 =    302622.688 :: beta factor
.    x 0.028 =       8505.21 :: sharpe factor
.    x 1.767 =     15032.122 :: target low factor
.    x 1.309 =     19674.277 :: target mean factor
.     x 1.11 =     21835.527 :: target high factor
.    x 1.312 =     28640.534 :: industry 2-weeks return factor
.    x 0.992 =     28409.246 :: overall "drift" factor
.    x 0.807 =     22913.881 :: largest single-day jump factor
.     x 1.01 =     23143.003 :: mean volatility factor
.    x 1.097 =     25397.689 :: 42-day mean volatility factor
.      x 1.0 =     25393.595 :: factor hist industry gain for week 15
.   cubeRoot =        29.393 :: reduced to standardize
.    - 21.35 =         8.043 :: add/subtract for performance
.                      8.043 :: FINAL WEIGHT for NASDAQ:CBMG


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org